Inactief instrument

Andere talen Myovant Sciences Ltd.

Aandelen

MYOV

BMG637AM1024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Sumitomo Pharma Unit Closes $1.7 Billion Purchase of Myovant Sciences	14-03-23
MYOVANT SCIENCES LTD. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events (form 8-K)	10-03-23
Myovant Sciences Ltd.(NYSE:MYOV) dropped from S&P Biotechnology Select Industry Index	10-03-23
Myovant Sciences Ltd.(NYSE:MYOV) dropped from S&P TMI Index	10-03-23
Myovant Sciences Ltd.(NYSE:MYOV) dropped from S&P Global BMI Index	10-03-23
Sumitovant Biopharma Ltd. completed the acquisition of remaining 47.83% stake in Myovant Sciences Ltd..	10-03-23
MYOVANT SCIENCES LTD. : Submission of Matters to a Vote of Security Holders (form 8-K)	01-03-23
LifeSci Index Partners	28-02-23
Myovant Sciences: Fiscal Q3 Earnings Snapshot	26-01-23
MYOVANT SCIENCES LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	26-01-23
Myovant Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	26-01-23
Earnings Flash (MYOV) MYOVANT SCIENCES Reports Q3 Revenue $100.2M	26-01-23
Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022	26-01-23
MYOVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV	25-01-23
Insider Sell: Myovant Sciences	20-01-23
MYOVANT SCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Myovant Sciences - MYOV	12-01-23
Lyell Immunopharma Names Lynn Seely as Chief Executive	15-12-22
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08	16-11-22
Myovant Sciences Announces New Employment Inducement Grants Under NYSE Rule 303A.08	16-11-22
Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources	16-11-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Myovant Sciences Ltd.

Aandelen

MYOV

BMG637AM1024

Andere talen

Filters